South African variant can 'break through' Pfizer vaccine, Israeli study says April 10, 2021 at 09:18PM

The study, released on Saturday, compared almost 400 people who had tested positive for Covid-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients with the disease. It matched age and gender, among other characteristics.